The journey from a laboratory hypothesis to a pharmacy shelf is one of the most grueling marathons in modern industry, typically spanning 10 to 15 years and billions of dollars in investment. Progress [...]
Alphabet's life sciences business Verily is restructuring and raising money as a new corporate entity. Verily announced that with its $300 million investment round, it will change from an LLC to [...]
Across 107 enterprises, AI infrastructure spending is accelerating well ahead of the ability to see or steer its economics. Most organizations run their AI on a familiar base of hyperscalers and model [...]
Across 101 enterprises, agent orchestration is consolidating onto model-provider platforms — Anthropic’s Claude leads by a wide margin — chosen for the gravity of the underlying model and judged [...]
OpenAI has introduced GPT-Rosalind, a reasoning model tailored for the life sciences. It's designed to help researchers move faster from hypothesis to experiment. Access is tightly controlled for [...]
OpenAI is offering its life sciences model GPT-Rosalind for free through the new Rosalind Biodefense program, aimed at pandemic preparedness and biodefense. Early partners include Lawrence Livermore N [...]
Across 157 enterprises, organizations are granting AI agents more autonomy while trusting the evaluations meant to gate that autonomy less. Half have already shipped an agent that passed their interna [...]
Across 107 enterprises, AI agents are being given real access to systems and data while the controls meant to contain them lag behind. More than half have already had a confirmed agent security incide [...]